针对原发性免疫缺陷疾病的免疫球蛋白疗法 (第二部分):对剂量策略的考虑
Zhaoyang Li1, Iftekhar Mahmood1
1Clinical Pharmacology & Early Clinical Development, Takeda Development Center Americas, Inc., Cambridge, MA 02142, USA.
Immunotherapy
|September 26, 2024
概括
针对原发性免疫缺陷疾病 (PID) 的个性化免疫球蛋白G (IgG) 剂量需要仔细监测IgG水平和患者因素. 优化静脉注射 (IVIG) 和皮下注射 (SCIG) 的IgG治疗效益需要严格评估剂量策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 初级免疫缺陷疾病 (PID) 需要免疫球蛋白G (IgG) 替代疗法.
- 当前IgG剂量是个性化的,依赖于血清IgG水平,病史,临床状态和医生的判断.
- 静脉注射 (IVIG) 和皮下注射 (SCIG) 的IgG注射途径,包括用 hialuronidase促进的SCIG,都需要评估,以获得最佳的治疗结果.
研究的目的:
- 审查PIDsIgG剂量策略的当前和未来前景.
- 讨论不同IgG疗法类型和注射途径的考虑因素.
- 针对特定的患者群体,包括新开始免疫球蛋白治疗的患者和在IVIG和SCIG之间切换的患者.
主要方法:
- 对当前IgG剂量策略的文献综述.
- 影响IgG剂量确定因素的分析.
- 讨论IgG疗法管理中的挑战和未来方向.
主要成果:
- 血清IgG监测至关重要,但对于最佳PID治疗是不够的.
- 个性化剂量考虑了多个患者特异性的因素.
- 优化IVIG和SCIG的频率和剂量是最大化治疗效益的关键.
结论:
- 针对PID的有效IgG剂量是一个复杂的,多因素的过程.
- 需要继续进行研究,以完善IgG剂量策略,以满足患者的各种需求.
- 对IgG治疗的个性化方法对于有效管理PID至关重要.
相关概念视频
Immunodeficiency Diseases
919
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
919
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Humoral Immune Responses
72.2K
Overview
72.2K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


